Company / R&D Expense
NutriBand Inc. R&D Expense History
FY2022-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$3.1M
FY2026
5-year range
$411.4K / $3.1M
FY2022-FY2026
Trend
+59.1%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has increased for 3 consecutive years, from $411,383 in FY2023 to $3M in FY2026.
Based on SEC 10-K filings.
$3M in FY2026 with a 3-year CAGR of +96.5%.
Improved from $982,227 to $3M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +96.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- NutriBand Inc.'s r&d expense has grown for 3 consecutive years.
- 3-year CAGR of +96.5%, indicating consistent growth.
- In FY2026, r&d expense increased 59.1% year-over-year.
- Lowest r&d expense in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $3.1M | +59.1% |
| FY2025 | $2.0M | +99.6% |
| FY2024 | $982.2K | +138.8% |
| FY2023 | $411.4K | +0.0% |
| FY2022 | $411.4K | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026